Statement Of Changes In Equity [Abstract]

Innate Pharma - Filing #5981200

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Increase (decrease) through appropriation of retained earnings, equity	— EUR	7 570 EUR	— EUR	— EUR	— EUR	7 570 EUR	— EUR	— EUR	— EUR	— EUR	58 103 EUR	— EUR	— EUR	58 103 EUR	— EUR	— EUR